StockMarketWire.com - Redx Pharma has issued 6.18m shares of 1 pence each in connection with the placing announced by the Company on 24 March 2016.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

Following Admission, the Company's total issued share capital will comprise 71,161,406 Ordinary Shares.

This number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.






Story provided by StockMarketWire.com